Company Filing History:
Years Active: 2011-2013
Title: Innovations by Alexandra Glausch
Introduction
Alexandra Glausch is a notable inventor based in Weil am Rhein, Germany. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of injectable depot formulations. With a total of 4 patents to her name, her work has garnered attention for its innovative approach to drug delivery systems.
Latest Patents
One of her latest patents is an injectable depot formulation comprising crystals of iloperidone. This formulation features crystals with a specific structure, where the X50 value of the crystals ranges from 1 to 200 microns. The advantages of these depot formulations include the ability to correlate the release and absorption of the crystals in plasma with their size. Additionally, the particle size can be controlled through crystal engineering and milling techniques. Importantly, these crystals demonstrate stability during storage and are resilient to sterilization procedures, such as gamma irradiation.
Career Highlights
Alexandra Glausch has established herself as a key figure in her field through her innovative research and development efforts. Her work at Novartis AG has allowed her to explore and implement cutting-edge technologies in drug formulation.
Collaborations
She has collaborated with notable colleagues, including Dierk Wieckhusen and Markus Ahlheim, to advance her research and contribute to the pharmaceutical industry.
Conclusion
Alexandra Glausch's contributions to injectable depot formulations highlight her innovative spirit and dedication to improving drug delivery systems. Her work continues to influence the pharmaceutical landscape, showcasing the importance of research and collaboration in driving advancements in healthcare.